Neuroendocrine dysfunction following mild TBI: When to screen for it
Consider lab studies when suggestive symptoms last >3 months, or if delayed symptoms appear anytime up to 3 years after the injury.
The research areas given the highest priority by the group were incidence and prevalence studies of pituitary dysfunction after TBI in the combat military population, including pre- and postdeployment rates of dysfunction and the incidence of comorbidities. Also of benefit would be a retrospective study of the consequences of pituitary dysfunction that additionally addresses the effects of comorbid conditions commonly associated with TBI. Considering the rapid expansion in the field of mTBI, additional research and provider awareness concerning early identification and treatments may improve the outcomes for those with persistent mTBI symptoms.
CORRESPONDENCE
Theres A. West, DNP, APN, BC, Defense and Veterans Brain Injury Center, 1335 East West Highway, 6th floor, Silver Spring, MD 20910; therese.a.west.ctr@mail.mil
